Fundraising Fox
OCCIDENT
Venture capitalMunich · Pre-Seed–Series A · 4 people tracked
Find your way into OCCIDENT
Each arrow is one introduction. Sign up to fill in the first one.
Ask Aagam Shah to introduce you to Michael Pauer
You →Aagam · together at OCCIDENT →Michael
Ask Jamie Chen to introduce you to Patrizia Schützenhöfer
You →Jamie · together at OCCIDENT →Patrizia
Ask Sam Okafor to introduce you to Cédric Barra
You →Sam · together at OCCIDENT →Cédric
- Paul Sunzenauer28 people can intro you
Sign up to find every way you can get introduced to OCCIDENT
- Your email: who you already know at OCCIDENT, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the OCCIDENT team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
OCCIDENT invests in deep-tech startups that transfer promising scientific findings into concrete applications, financing spin-offs from research whose innovations address societal challenges and create value. The firm invests its own capital, takes a long-term view focused on sustainable success potential, and supports portfolio companies financially and with entrepreneurial experience. Its focus areas include life sciences and biotechnology as well as industrial tech. Positioning itself as 'The Science Investor,' OCCIDENT emphasizes an entrepreneurial mindset in portfolio management, from deal sourcing and due diligence through closing and active support, aiming to bring innovations to market success 'the OCCIDENT way.'
Source: firm website, verified Aug 3, 2026.
Team · 4 people
from the firm's websiteWhat they invest in
from 15 of 20 portfolio companiesMedical Devices ×9Biotech ×8Deep Tech ×6Healthtech ×4Advanced Manufacturing ×2Digital Health ×2Hardware ×2Media & Entertainment ×2
HQs:Switzerland×6Germany×4Slovenia×1
Who they back
founder profiles across 8 portfolio companiesFounding team size:solo founder×62 founders×13 founders×1
Investments · 20 tracked
founders shown can be your intro pathBy year:2026 · 12024 · 22022 · 14 dated
Algiax Pharmaceuticals is a clinical-stage biotech company developing small-molecule GABAA receptor modulators to treat neuropathic pain and other conditions with high unmet medical need.
BiotechMedical DevicesErkrath, DE
Dr. Guido Koopmans(Chief Scientific Officer)Dr. Birgit Hasse(Head of CMS and Regulator Affairs)
Co-investorsKfW
Immitra Bio develops an in-vivo stem cell therapy platform designed to treat rare genetic diseases, particularly severe inherited red blood cell disorders, by replacing complex transplants with single off-the-shelf treatments.
BiotechDeep TechMedical DevicesZürich, CH
Amir Taheri(Co-founder and Chief Scientific Officer)inJacob Corn(Co-founder and Scientific Advisor)inJan Nelis(Co-founder and Chief Executive Officer)in
Co-investorsKickfundanother.vcBackbone VenturesVenture Kick
Altavo develops non-invasive silent speech technology using RF sensing and artificial intelligence to help patients who have lost their voice regain natural-sounding speech.
AI & Machine LearningDeep TechMedical DevicesDresden, DE
Rudolf
Co-investorsNovalis Biotech
Avelo develops diagnostic technology aimed at closing the diagnostic gap in respiratory disease, so patients receive timely and accurate information for effective treatment.
BiotechDigital HealthHealthtechMedical Devices
Co-investorsPrivilège Ventures
Chipmetrics provides 3D metrology solutions using test chips and wafers for semiconductor process control, serving semiconductor manufacturers and material developers optimizing deposition processes and yields.
Advanced ManufacturingDeep TechHardwareSemiconductors
Co-investorsBerliner Volksbank VenturesInnovestor VenturesRedstoneTane FundHTGFInnovestor
Core Sensing develops integrated wireless sensor systems that measure force, torque, and other physical quantities directly on components, delivering data to cloud platforms and dashboards for condition monitoring and predictive maintenance applications.
Advanced ManufacturingHardwareIoT
Simon Krech(Founder)in
EBAMed develops non-invasive cardiac ablation technology using particle/proton beam therapy to treat cardiac arrhythmias, with in-house R&D focused on medical devices and cardiac software.
HealthtechMedical Devices
Giovanni Leo(Co-Founder)Douglas Packer(Co-Founder & Key Advisor)Ugo Amaldi(Co-Founder & Key Advisor)Marina Izzo(Chief Executive Officer & Director)inAdriano Garonna(Chief Technology Officer)inOlivier Coquoz(Head of R&D)
Co-investorsCDP Venture CapitalElysia CapitalLIFTT
iMusician is a music distribution and artist management platform that enables independent musicians and labels to upload, distribute, and monetize their music across global streaming platforms.
B2B MarketplacesCreator EconomyMedia & EntertainmentSaaSGeneva, CH
Tobias Wirz(Founder)in
Startup that credited Venture Kick with helping establish its customer and market focus.
Co-investorsSICTICVenture KickZEISS Ventures
Lunaphore develops spatial biology solutions that enable scientists and clinicians to analyze tissue structure and cellular composition.
BiotechDeep TechMedical DevicesLausanne, CH
Co-investorsPolytech Ecosystem VenturesZühlke Ventures
ReCatalyst develops a nanotechnology catalyst platform aimed at reducing dependency on scarce platinum group metals, starting with carbon-supported platinum-based catalysts for hydrogen technologies like fuel cells and water electrolysers.
CleantechDeep TechNew Materials
Co-investorsxista science ventures
Resistell develops a nanomotion-based diagnostic device for rapid phenotypic antibiotic susceptibility testing (AST), aimed at accelerating detection of antibiotic resistance in hospital settings.
BiotechHealthtechMedical Devices
Dr. Danuta Cichocka(CEO, Co-Founder, Board Member)inGrzegorz Gonciarz(COO)inDr. Alex Sturm(Chief Scientific Officer)inMartin Birk(CFO)in
Co-investorsAlpana VenturesTRUMPF Venture
StartupTicker is a Swiss platform that maintains a public database of over 200 venture capitalists, business angel clubs, and corporate venture funds that have invested in Swiss startups.
Media & EntertainmentSector AgnosticSwitzerland, CH
Co-investorsSICTIC
Thermosome is a drug development company working on targeted tumor therapy combined with immune stimulation, using a tumor targeting approach designed to increase local drug concentrations for better treatment outcomes in cancer patients.
BiotechHealthtech
Co-investorsBayern Kapitalcoparion
The page is a placeholder shell showing only cookie/consent notices for embedded third-party content (Vimeo, YouTube, reCAPTCHA, social media) and contains no substantive information about the company.
Dominik Schumacher(Founder)in
Co-investorsAndera PartnersAscenta CapitalBayern KapitalBioMedPartnerscoparionFrazier Life Sciences+5 more
GENFIT is a biopharmaceutical company developing therapies for rare, life-threatening liver diseases, with a focus on acute-on-chronic liver failure (ACLF), hepatic encephalopathy (HE), cholangiocarcinoma, urea cycle disorders, and organic acidemias.
BiotechDigital HealthMedical Devices
Co-investorsVerve VenturesEsperante VenturesHealthequityredalpine
.jpeg){kind=logo}
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
gmetricsGna BioLymphatica Medtech
Exits · 2
2 acquisitionsTubulis GmbHacq. by Gilead SciencesVersantisacq. by GENFIT
Portfolio news
latest coverage across their companiesImmitra Bio · eu-startups.com · Jul 22, 2026
Altavo · finsmes.com · Jan 23, 2026
Chip Metrics · chipmetrics.com · Dec 3, 2025
Frequently asked questions
- How many investments has OCCIDENT made?
- OCCIDENT has 20 tracked investments, 2 of which have exited, including 1 dated in the last 24 months.
- What stage does OCCIDENT invest at?
- OCCIDENT invests at the Pre-Seed, Seed, Series A stages.
- What sectors does OCCIDENT focus on?
- OCCIDENT focuses on Advanced Manufacturing, Biotech, Deep Tech, Hardware, Healthtech.
- Where is OCCIDENT located?
- OCCIDENT is headquartered in Munich, DE.
- Who does OCCIDENT co-invest with?
- OCCIDENT most often shares deals with Bayern Kapital, CDP Venture Capital, coparion, among 27 tracked co-investors.
Similar investors
Lux Capital is a venture capital firm that backs founders building transformative deep technologies, having been among the first investors in category-defining companies across AI, robotics, biotech, defense, and infrastructure.
Snatched Ventures is a San Francisco-based early-stage venture capital firm backing DeepTech startups focused on sustainable innovation and operational transformation. It is led by a two-GP team combining corporate development and institutional investment management experience.
SOSV is a deep tech venture capital firm that makes first-check pre-seed investments and follow-on rounds in startups focused on human and planetary health, providing lab space and hands-on support at its US locations.
Artesian is a deep tech and hardware venture capital investor that builds funds around specific institutional backers — governments, corporations, universities, industry bodies and super funds — to pursue both financial returns and strategic outcomes in critical industries.
UKI2S (UK Innovation & Science Seed Fund) is a UK national seed investment fund that invests in and supports early-stage businesses and spinouts, with a focus on science and technology companies from pre-seed through exit.